SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Hannover House, Inc. (HHSE) trades at a trailing P/E of 29.7. Trailing earnings yield is 3.37%.
Criteria proven by this page:
- VALUE (60/100, Pass) — composite valuation score exceeds the 60/100 pass threshold.
- Trailing Earnings Yield 3.37% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
Overall SharesGrow Score: 80/100 with 5/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
60/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HHSE
Valuation Multiples
P/E (TTM)29.7
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio16.86
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.37%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$0.00 |
$6.52M |
$1.36M |
20.9% |
| 2016 |
$0.00 |
$2.05M |
$654.9K |
32% |
| 2017 |
$0.00 |
$949.43K |
$173.24K |
18.2% |
| 2018 |
$0.00 |
$846.92K |
$110.61K |
13.1% |
| 2019 |
$0.00 |
$188.14K |
$-58.64K |
-31.2% |
| 2020 |
$0.00 |
$489.1K |
$-247.32K |
-50.6% |
| 2021 |
$0.00 |
$350.72K |
$126.44K |
36.1% |
| 2022 |
$0.00 |
$203.62K |
$36.64K |
18% |
| 2023 |
$0.00 |
$512.74K |
$46.98K |
9.2% |
| 2024 |
$0.00 |
$599.07K |
$351.38K |
58.7% |
